期刊文献+

利伐沙班相关杂质的溯源与合成

Traceability and Synthesis of Rivaroxaban-related Impurities
下载PDF
导出
摘要 本文依据利伐沙班原研合成工艺路线,参考利伐沙班片进口药品质量标准对利伐沙班相关杂质进行了溯源,并对其中的相关杂质Rivaroxaban Impurity A,B,E,F,G进行了合成与1H-NMR表征,为利伐沙班原料药的质量控制研究提供帮助。 In this strudy,the traceability of Rivaroxaban-related impurities was investigated based on the synthesis route of Rivaroxaban as well as the quality standard of imported Rivaroxaban.The synthesis and 1H NMR characterization of the corresponding Rivaroxaban impurities A,B and E‒G were also carried out,which will be helpful to the studies of quality control of Rivaroxaban raw material.
作者 吴毅武 Wu Yiwu(Guangzhou Henovcom Bioscience Co.,Ltd.,Guangzhou 510000,China)
出处 《广东化工》 CAS 2021年第4期40-42,共3页 Guangdong Chemical Industry
关键词 利伐沙班 关健杂质 合成 Rivaroxaban key impurity synthesis
  • 相关文献

参考文献2

二级参考文献11

  • 1Becker R, Berkowitz SD, Breithardt G, et al. Rivaroxaban- once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation: rationale and design of the ROCKET AF study [J]. Am Heart J, 2010, 159 (3) : 340-347.
  • 2Roehring S, Straub A, Pohlmann J, et al. Discovery of the novel antithrombotic agent 5-chloro-N-( { (5S)-2- oxo-3- [4- (3-oxomorpholin-4-yl) phenyl] - 1,3-oxazolidin-5- yl}methyl) thiophene-2-carboxamide- (BAY-59-7939) : an oral, direct factor Xa inhibitor EJ]. J Med Chem, 2005, 48: 5900-5908.
  • 3Mangion B. Process for determining the suitability for distribution of a batch of a thiophene-2-carboxamide derivative: WO, 2012035057 [P]. 2012-03-22.
  • 4Mark A, Matulenko, Meyers AI. Total synthesis of (-)-tetrahydropalmatine via chiral formamidine carbanions: unexpected behavior with certain ortho-substituted electrophiles EJ]. J Org Chem, 1996, 61: 573-580.
  • 5Fabrichnyi BP, Bulgakova VN, Gol'dfarb YL. Beckmann rearrangement of acetylthiophene oxime bcnzcncsulfonates as a method for the synthesis of acetamidothiophenes [J]. Chem Heterocycl Compd, 1985, 21 (4) : 401-403.
  • 6利伐沙班在加拿大和欧盟获得上市批准[J].中国医药导刊,2008,10(7):1061-1061. 被引量:1
  • 7袁静,黄长江,张俊伟,张士俊,徐为人.利伐沙班的合成[J].中国新药杂志,2010,19(23):2185-2187. 被引量:18
  • 8罗玲艳,申东升,周宗洲,谭诚,黄英堂.4-(4-氨基苯基)-3-吗啉酮的合成[J].中国医药工业杂志,2011,42(2):93-95. 被引量:7
  • 9田国祥,魏万林,张灵.后华法林时代口服抗凝新秀:达比加群、利伐沙班、阿哌沙班[J].中国循证心血管医学杂志,2011,3(5):403-406. 被引量:23
  • 10蔡正艳,温颖玲,张顺利,刘珍仁,郝群.利伐沙班有关物质的合成及结构确定[J].中国医药工业杂志,2014,45(4):303-307. 被引量:5

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部